Sodium-Glucose Cotransporter-2 Inhibitors and Cardiorenal Events in Nonalbuminuric Kidney Disease
This nationwide cohort study showed that SGLT2is use was associated with a significantly lower risk of progression to macroalbuminuria, and all-cause mortality compared with nonuse in patients with T2D and nonalbuminuric CKD.
Authors
- WU Yi-ling
- Jia-Sin Liu
- Keong Chong
- Fu-Shun Yen
- Chii-Min Hwu
- Chih-Cheng Hsu
- James Cheng-Chung Wei
- Chih-Ming Chen
- Chien-Wei Huang
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Health Research Institutes (TW)
- China Medical University (TW)
- Min Sheng General Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1016/j.ekir.2025.103756
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00